ivonescimab
akesobio,ishares biotechnology,spdr s&p biotech
['ivonescimab', '$ibb', '$xbi']
new promising data for ivonescimab, an investigational innovative bispecific, showcased at asco 2023 more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt